News Hub

Real-time financial, economic, and global news with market-focused context and analysis.

Coverage spans equities, macroeconomic data, commodities, currencies, technology, politics, and global events—paired with analysis that highlights why each development matters for traders and investors. From breaking headlines to hourly market snapshots and in-depth articles, the News Hub is designed to help you stay informed, oriented, and ahead of market-moving events.

  • ADP private payrolls, two services PMIs and EIA crude inventories are due Wednesday, set to reprice rates, equities and commodity markets.
  • SpaceX short interest reached extreme levels and Musk's public warning raises odds of significant post-earnings volatility.
  • A mass migrant surge into Ceuta left thousands stranded and officials report more than 80 deaths.
  • European wheat futures fell after oil slid and traders reassessed Black Sea export disruption risks.
  • Tech and retail stocks led wide intraday swings across mega- to small-caps after earnings and guidance moves.
  • XPLR Infrastructure is being pitched as a short, with a $8.20 entry, $11 stop and $4.80 target over ~45 trading days.
  • Analysts flagged Bombardier as a buy after price crossed key moving averages and momentum indicators turned positive.

Latest Articles

Veeva Systems Director Executes Planned Stock Sale Amid Market Shifts

Veeva Systems Director Executes Planned Stock Sale Amid Market Shifts

Veeva Systems Inc (NASDAQ:VEEV) has seen recent insider activity and significant corporate milestones. Priscilla Hung, a director at the firm, completed a sale of Class A Common Stock on April 30, 2026. This transaction occurred as part of a pre-established trading plan, amid a period of broader organizational changes including an index inclusion a…

Opaleye Management Divests Over $574,000 in SANUWAVE Health Common Stock

Opaleye Management Divests Over $574,000 in SANUWAVE Health Common Stock

Opaleye Management Inc., a major stakeholder in SANUWAVE Health, Inc. (NASDAQ:SNWV), has executed a series of stock sales totaling $574,240. The transactions, which took place over two consecutive trading sessions on April 30 and May 1, 2026, involve shares held through Opaleye, L.P. and a separately managed account. This divestment comes at a time…

Firefly Aerospace Announces First Quarter 2026 Financial Results

Firefly Aerospace Announces First Quarter 2026 Financial Results

Firefly Aerospace announced strong first quarter 2026 financial results with record revenue of $80.9 million, a 40% increase from the previous quarter. The company secured significant contracts with the U.S. Space Force including the space-based interceptor program under Golden Dome and an engineering change proposal valued at $109 million. Firefly…

Adeia Announces CEO Paul Davis to Step Down by the Fourth Quarter of 2026; Board Launches Search Process

Adeia Announces CEO Paul Davis to Step Down by the Fourth Quarter of 2026; Board Launches Search Process

Adeia Inc., a technology and IP licensing company serving the semiconductor and media industries, announced that CEO Paul Davis will step down by the fourth quarter of 2026 to focus on health and personal pursuits. Davis will remain in position until a successor is named. The Board has launched a search led by a transition committee, supported by a…

ThredUp Announces First Quarter 2026 Results

ThredUp Announces First Quarter 2026 Results

ThredUp Inc. reported a 15% YoY revenue increase to $81.7 million in Q1 2026, with record active buyers growing 25% to 1.71 million. The company improved gross margin slightly to 79.2% and adjusted EBITDA margin to 3.4%. Despite a net loss, ThredUp raised its full-year 2026 revenue, gross margin, and adjusted EBITDA margin guidance, signaling confi…

Capricor Therapeutics to Report First Quarter 2026 Financial Results and Provide Recent Corporate Update on May 12

Capricor Therapeutics to Report First Quarter 2026 Financial Results and Provide Recent Corporate Update on May 12

Capricor Therapeutics, a biotech firm specializing in cell and exosome-based therapies for rare diseases, will release its Q1 2026 financial results on May 12, 2026, followed by a conference call and webcast. The company highlighted its lead candidate, Deramiocel, targeting Duchenne muscular dystrophy, and discussed its proprietary StealthX platfor…

Kyntra Bio to Report First Quarter 2026 Financial Results

Kyntra Bio to Report First Quarter 2026 Financial Results

Kyntra Bio, a biopharmaceutical company focused on oncology and rare diseases, will report its first quarter 2026 financial results on May 11, 2026, followed by a conference call with investors. The company is advancing multiple drug candidates including Roxadustat, approved in several countries for anemia related to chronic kidney disease, and FG-…

Silvaco Announces Participation at Upcoming Investor Conferences

Silvaco Announces Participation at Upcoming Investor Conferences

Silvaco Group, Inc., a provider of AI-enabled TCAD, EDA software, and SIP solutions for semiconductor design, announced that its CEO, Walden Rhines, and CFO, Chris Zegeralli, will participate in the Needham Technology, Media, and Consumer Conference and the B. Riley Securities 2026 Investor Conference. The company will offer live webcasts of these …

AH Realty Trust Reports First Quarter 2026 Results

AH Realty Trust Reports First Quarter 2026 Results

AH Realty Trust reported its first quarter 2026 financial results, announcing a GAAP net loss of $0.33 per diluted share but achieving increased Funds From Operations (FFO), As Adjusted to $0.15 per diluted share. The company implemented a major business restructuring focused on exiting the multifamily sector, divesting construction and financing b…

EverQuote Announces First Quarter 2026 Financial Results

EverQuote Announces First Quarter 2026 Financial Results

EverQuote, Inc. announced its first quarter 2026 results showing 15% year-over-year revenue growth to $190.9 million, net income of $18.7 million, and a 30% increase in adjusted EBITDA to a record $29.3 million. The company exceeded guidance across all financial metrics and projects continued growth in Q2, driven by AI-powered solutions and expansi…

Gaia Reports First Quarter 2026 Financial Results

Gaia Reports First Quarter 2026 Financial Results

Gaia, Inc. reported a 2% increase in revenue to $24.3 million for Q1 2026 versus the prior year, while gross profit remained flat. The company is strategically shifting focus from third-party subscriber growth to expanding direct membership to improve subscriber value and retention. Despite a modest increase in net loss to $1.3 million, Gaia contin…

Adeia Announces First Quarter 2026 Financial Results

Adeia Announces First Quarter 2026 Financial Results

Adeia Inc. announced robust first quarter 2026 results, with $105 million revenue, $58 million operating cash flow, and a high adjusted EBITDA margin of 60%. The company secured eight license agreements, including new multi-year contracts with AMD and Microsoft, driving diversification beyond Pay-TV into semiconductors, consumer electronics, social…

Devon Energy and Coterra Energy Shareholders Approve Merger

Devon Energy and Coterra Energy Shareholders Approve Merger

Shareholders of Devon Energy Corporation and Coterra Energy Inc. have approved the all-stock merger, expected to close around May 7, 2026. The merger will create a larger company with complementary asset bases, aiming to enhance margins, accelerate free cash flow growth, and increase shareholder returns. Devon shareholders will own about 54% and Co…

Aktis Oncology Initiates Phase 1b Clinical Trial for AKY-2519, a B7-H3 Miniprotein Radioconjugate, in Metastatic Castration-Resistant Prostate Cancer (mCRPC)

Aktis Oncology Initiates Phase 1b Clinical Trial for AKY-2519, a B7-H3 Miniprotein Radioconjugate, in Metastatic Castration-Resistant Prostate Cancer (mCRPC)

Aktis Oncology initiated a Phase 1b clinical trial for AKY-2519, a B7-H3 targeted miniprotein radioconjugate, evaluating it in metastatic castration-resistant prostate cancer (mCRPC) patients including those naïve and experienced with PLUVICTO®. A parallel Phase 1b basket trial is planned for other B7-H3 expressing tumors such as lung and colorecta…

NFT LTD Files Annual Report on Form 20-F for Fiscal Year 2025

NFT LTD Files Annual Report on Form 20-F for Fiscal Year 2025

NFT Limited (NYSE American: MI), an online platform for international art and collectibles trading, announced the filing of its 2025 annual report (Form 20-F) with the SEC. The report includes audited financial statements featuring a going concern emphasis paragraph from the independent auditor, signaling uncertainty about the company’s ability to …

James River Announces First Quarter 2026 Results

James River Announces First Quarter 2026 Results

James River Group Holdings, Inc. announced its financial results for Q1 2026, showing a net loss primarily due to $6.7 million in reinsurance reinstatement premiums linked to a major claim. Despite this, the company saw modest growth in its excess and surplus casualty lines and reduced general administrative expenses by 10.5%. Investment income ros…